Targeting B cells in the pre-phase of systemic autoimmunity globally interferes with autoimmune pathology

Systemic lupus erythematosus (SLE) is characterized by a loss of self-tolerance, systemic inflammation, and multi-organ damage. While a variety of therapeutic interventions are available, it has become clear that an early diagnosis and treatment may be key to achieve long lasting therapeutic respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Anja, Schäfer, Simon, Zaytseva, Olga, Albert, Heike, Lux, Anja, Krištić, Jasminka, Pezer, Marija, Lauc, Gordan, Winkler, Thomas, Nimmerjahn, Falk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455742/
https://www.ncbi.nlm.nih.gov/pubmed/34585117
http://dx.doi.org/10.1016/j.isci.2021.103076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455742/
https://www.ncbi.nlm.nih.gov/pubmed/34585117
http://dx.doi.org/10.1016/j.isci.2021.103076

Ejemplares similares